AAAAAA
Results:
1-19
|
Results: 19
Authors:
HOWES J
NOVACK GD
Citation: J. Howes et Gd. Novack, FAILURE TO DETECT SYSTEMIC LEVELS, AND EFFECTS OF LOTEPREDNOL ETABONATE AND ITS METABOLITE, PJ-91, FOLLOWING CHRONIC OCULAR ADMINISTRATION, Journal of ocular pharmacology and therapeutics, 14(2), 1998, pp. 153-158
Authors:
NOVACK GD
HOWES J
CROCKETT RS
SHERWOOD MB
Citation: Gd. Novack et al., CHANGE IN INTRAOCULAR-PRESSURE DURING LONG-TERM USE OF LOTEPREDNOL ETABONATE, Journal of glaucoma, 7(4), 1998, pp. 266-269
Authors:
STEWART R
HORWITZ B
HOWES J
NOVACK GD
HART K
Citation: R. Stewart et al., DOUBLE-MASKED, PLACEBO-CONTROLLED EVALUATION OF LOTEPREDNOL ETABONATE0.5-PERCENT FOR POSTOPERATIVE INFLAMMATION, Journal of cataract and refractive surgery, 24(11), 1998, pp. 1480-1489
Authors:
HOWES J
JOHN D
MINARD RA
Citation: J. Howes et al., RESOLVING THE PARADOX OF ENVIRONMENTAL-PROTECTION, Issues in science and technology, 14(4), 1998, pp. 57-64
Authors:
BEEHLER C
BODNER B
BOWMAN B
COOKE D
CRABB JL
DEBARGE LR
DONNENFELD E
ESTOPINAL M
FOX K
KASTL P
OLANDER K
SHARPE E
SHOFNER R
STAHL J
STEVENSON D
STEWART W
WALTERS T
GILL S
HOWES J
LAWSON C
SMERICK M
ZACCARDELLI D
FAZIO R
NOVACK GD
CROCKETT RS
HART K
Citation: C. Beehler et al., A DOUBLE-MASKED, PLACEBO-CONTROLLED EVALUATION OF 0.5-PERCENT LOTEPREDNOL ETABONATE IN THE TREATMENT OF POSTOPERATIVE INFLAMMATION, Ophthalmology (Rochester, Minn.), 105(9), 1998, pp. 1780-1786
Authors:
DELL SJ
LOWRY GM
NORTHCUTT JA
HOWES J
NOVACK GD
HART K
Citation: Sj. Dell et al., A RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED PARALLEL STUDY OF 0.2-PERCENT LOTEPREDNOL ETABONATE IN PATIENTS WITH SEASONAL ALLERGIC CONJUNCTIVITIS, Journal of allergy and clinical immunology, 102(2), 1998, pp. 251-255
Authors:
STRAHLMAN E
HOWES J
Citation: E. Strahlman et J. Howes, A RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDYOF THE EFFECTS OF LOTEPREDNOL ETABONATE 0.2-PERCENT OPHTHALMIC SUSPENSION (LE) IN PATIENTS WITH SEASONAL ALLERGIC CONJUNCTIVITIS, Investigative ophthalmology & visual science, 38(4), 1997, pp. 1025-1025
Authors:
ZBYSZYNSKI B
ABELSON M
HOWES J
Citation: B. Zbyszynski et al., A RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED PAIRED-COMPARISON OF LOTEPREDNOL ETABONATE 0.5-PERCENT OPHTHALMIC SUSPENSION (LE) BID OR QID VERSUS PLACEBO IN AN ANTIGEN CHALLENGE MODEL OF ACUTE ALLERGIC CONJUNCTIVITIS, Investigative ophthalmology & visual science, 38(4), 1997, pp. 2012-2012
Authors:
GEORGE M
ABELSON M
HOWES J
Citation: M. George et al., A RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED PAIRED-COMPARISON OF LOTEPREDNOL ETABONATE 0.1-PERCENT, 0.2-PERCENT OR 0.3-PERCENT OPHTHALMIC SUSPENSION (LE) VERSUS PLACEBO IN AN ANTIGEN CHALLENGE MODEL OF ACUTE ALLERGIC CONJUNCTIVITIS, Investigative ophthalmology & visual science, 38(4), 1997, pp. 2019-2019
Authors:
HOWES J
STRAHLMAN E
Citation: J. Howes et E. Strahlman, A RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDYOF THE EFFECTS OF LOTEPREDNOL ETABONATE 0.2-PERCENT OPHTHALMIC SUSPENSION (LE) IN PATIENTS WITH SEASONAL ALLERGIC CONJUNCTIVITIS, Investigative ophthalmology & visual science, 38(4), 1997, pp. 2020-2020
Authors:
HOWES J
Citation: J. Howes, PETROLEUM SYSTEMS, RESOURCES OF SOUTHEAST-ASIA, AUSTRALASIA, Oil & gas journal, 95(50), 1997, pp. 52-56
Authors:
SHARMA V
HOWES J
COHEN AT
Citation: V. Sharma et al., PROSPECTIVE SURVEILLANCE FOR PERIOPERATIVE VENOUS THROMBOSIS, Archives of surgery, 132(2), 1997, pp. 212-212
Authors:
DELL SJ
SHULMAN DG
LOWRY GM
HOWES J
BERDY G
EMBRY S
FOX K
HORWITZ B
KUNESHPART K
LAIBOVITZ R
LEVIN J
LOWRY G
ORLANDO R
PARKS D
WALTERS T
COULTAS S
HART K
CROCKETT RS
NOVACK GD
Citation: Sj. Dell et al., A CONTROLLED EVALUATION OF THE EFFICACY AND SAFETY OF LOTEPREDNOL ETABONATE IN THE PROPHYLACTIC TREATMENT OF SEASONAL ALLERGIC CONJUNCTIVITIS, American journal of ophthalmology, 123(6), 1997, pp. 791-797
Authors:
FRIEDLAENDER MH
HOWES J
Citation: Mh. Friedlaender et J. Howes, A DOUBLE-MASKED, PLACEBO-CONTROLLED EVALUATION OF THE EFFICACY AND SAFETY OF LOTEPREDNOL ETABONATE IN THE TREATMENT OF GIANT PAPILLARY CONJUNCTIVITIS, American journal of ophthalmology, 123(4), 1997, pp. 455-464
Authors:
FRIEDLAENDER M
ASBELL P
HOWES J
Citation: M. Friedlaender et al., THE ROLE OF LOTEPREDNOL ETABONATE IN THE TREATMENT OF GIANT PAPILLARYCONJUNCTIVITIS AND SEASONAL ALLERGIC CONJUNCTIVITIS, Vision research, 36, 1996, pp. 1227-1227
Authors:
NOVACK GD
HOWES J
Citation: Gd. Novack et J. Howes, FAILURE TO DETECT SYSTEMIC LEVELS, AND EFFECTS OF LOTEPREDNOL ETABONATE AND ITS METABOLITE PJ-91 FOLLOWING CHRONIC OCULAR ADMINISTRATION, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 59-59
Authors:
CROPANZANO R
CITERA M
HOWES J
Citation: R. Cropanzano et al., GOAL HIERARCHIES AND PLAN REVISION, Motivation and emotion, 19(2), 1995, pp. 77-98
Authors:
HOWES J
BREWSTER ME
HARRIS A
GRIFFIN W
GARTY N
Citation: J. Howes et al., BUCCAL AND PARENTERAL CLINICAL-EVALUATION OF A BRAIN-TARGETING ESTRADIOL CHEMICAL DELIVERY SYSTEM (E2-CDS), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 172-172
Authors:
HOWES J
LENZ R
Citation: J. Howes et R. Lenz, CEREBROSPINAL-FLUID CUTANEOUS FISTULA - AN UNUSUAL COMPLICATION OF EPIDURAL-ANESTHESIA, Anaesthesia, 49(3), 1994, pp. 221-222
Risultati:
1-19
|